Defining long-term drivers of pertussis resurgence, and optimal vaccine control strategies
- 1 October 2015
- Vol. 33 (43) , 5794-5800
Abstract
No abstract availableKeywords
Funding Information
- NHMRC (CDF1061321)
- ARC (FT110100250)
This publication has 30 references indexed in Scilit:
- Changing Pertussis Epidemiology: Everything Old is New AgainThe Journal of Infectious Diseases, 2014
- Duration of Protection After First Dose of Acellular Pertussis Vaccine in InfantsPediatrics, 2014
- Can vaccine legacy explain the British pertussis resurgence?Vaccine, 2013
- Perplexities of pertussis: recent global epidemiological trends and their potential causesEpidemiology and Infection, 2013
- Waning Protection after Fifth Dose of Acellular Pertussis Vaccine in ChildrenNew England Journal of Medicine, 2012
- Increased Population Prevalence of Low Pertussis Toxin Antibody Levels in Young Children Preceding a Record Pertussis Epidemic in AustraliaPLOS ONE, 2012
- Natural immune boosting in pertussis dynamics and the potential for long-term vaccine failureProceedings of the National Academy of Sciences, 2011
- Estimating the Duration of Pertussis Immunity Using Epidemiological SignaturesPLOS Pathogens, 2009
- Using computer simulations to compare pertussis vaccination strategies in AustraliaVaccine, 2004
- Waning immunity and sub-clinical infection in an epidemic model: implications for pertussis in The NetherlandsMathematical Biosciences, 2000